• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Selective COX-2 inhibitors: a promise unfulfilled?

作者信息

Henry David, McGettigan Patricia

出版信息

Gastroenterology. 2007 Feb;132(2):790-4. doi: 10.1053/j.gastro.2007.01.017.

DOI:10.1053/j.gastro.2007.01.017
PMID:17261306
Abstract
摘要

相似文献

1
Selective COX-2 inhibitors: a promise unfulfilled?选择性环氧化酶-2抑制剂：一个未实现的承诺？
Gastroenterology. 2007 Feb;132(2):790-4. doi: 10.1053/j.gastro.2007.01.017.
2
[NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].[非甾体抗炎药治疗。传统非甾体抗炎药的胃肠道风险被低估了]
MMW Fortschr Med. 2010 May 20;152(20):46-7.
3
[Nonsteroidal anti-inflammatory agents--choice between disturbances of gastrointestinal tract and cardiovascular toxicity].
Medicina (Kaunas). 2006;42(5):429-39.
4
[Pathogen eradication prevents gastrointestinal complications].病原体根除可预防胃肠道并发症。
MMW Fortschr Med. 2007 Oct 25;149(43):58-9.
5
Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer.新型选择性环氧化酶-2抑制剂的介绍以及因出血和消化性溃疡穿孔而住院的发生率。
Aliment Pharmacol Ther. 2007 Apr 15;25(8):907-12. doi: 10.1111/j.1365-2036.2007.03274.x.
6
Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.质子泵抑制剂与非甾体抗炎药所致胃十二指肠溃疡出血和穿孔风险降低相关：一项巢式病例对照研究。
Arthritis Res Ther. 2007;9(3):R52. doi: 10.1186/ar2207.
7
[Frequency and severity of gastric and duodenal lesions induced by non-steroidal anti-inflammatory agents and aspirin].[非甾体抗炎药和阿司匹林所致胃及十二指肠病变的发生率与严重程度]
Gastroenterol Clin Biol. 1989 Mar;13(3):235-8.
8
Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population.普通人群中传统非甾体抗炎药和环氧化酶-2抑制剂使用者发生上消化道并发症的风险。
Gastroenterology. 2007 Feb;132(2):498-506. doi: 10.1053/j.gastro.2006.12.007. Epub 2006 Dec 3.
9
Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib.选择性COX-2抑制剂和非选择性非甾体抗炎药使用者因消化性溃疡和出血住院情况，特别提及塞来昔布
Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):982-8. doi: 10.1002/pds.1639.
10
[Safety of selective cyclooxygenase-2 inhibitors taken for a long time].长期服用选择性环氧化酶-2抑制剂的安全性
Bull Cancer. 2004 May;91 Suppl 2:S117-24.

引用本文的文献

1
Rofecoxib and clinically significant upper and lower gastrointestinal events revisited based on documents from recent litigation.基于近期诉讼文件重新审视罗非昔布与临床显著上、下胃肠道事件。
Am J Med Sci. 2011 Nov;342(5):356-64. doi: 10.1097/MAJ.0b013e3182113658.
2
[Concepts for perioperative pain therapy. A critical stocktaking].[围手术期疼痛治疗的概念。一次批判性评估]
Anaesthesist. 2009 Sep;58(9):914-6, 918-20, 922-6 passim. doi: 10.1007/s00101-009-1589-x.
3
Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.
非甾体抗炎药所致胃肠道毒性的管理：聚焦于质子泵抑制剂
Drugs. 2009;69(1):51-69. doi: 10.2165/00003495-200969010-00004.
4
[New substances and applications for postoperative pain therapy].[术后疼痛治疗的新物质与应用]
Schmerz. 2008 Jun;22(3):353-67; quiz 368-9. doi: 10.1007/s00482-008-0665-5.
5
Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: a randomized, double-blind, placebo-controlled study.在健康受试者中，使用20毫克奥美拉唑对短期使用非甾体抗炎药所致胃十二指肠不良影响的一级预防：一项随机、双盲、安慰剂对照研究。
Dig Dis Sci. 2008 Aug;53(8):2059-65. doi: 10.1007/s10620-007-0127-4. Epub 2008 Jan 26.
6
Clinical use and pharmacological properties of selective COX-2 inhibitors.选择性环氧化酶-2抑制剂的临床应用及药理特性
Eur J Clin Pharmacol. 2008 Mar;64(3):233-52. doi: 10.1007/s00228-007-0400-7. Epub 2007 Nov 13.
7
The bridging function of clinical pharmacology.临床药理学的桥梁作用。
Eur J Clin Pharmacol. 2007 Sep;63(9):817-9. doi: 10.1007/s00228-007-0347-8.